168 related articles for article (PubMed ID: 18633633)
1. Hepatic gap junctions in the hepatocarcinogen-resistant DRH rat.
Gotow T; Shiozaki M; Higashi T; Yoshimura K; Shibata M; Kominami E; Uchiyama Y
Histochem Cell Biol; 2008 Sep; 130(3):583-94. PubMed ID: 18633633
[TBL] [Abstract][Full Text] [Related]
2. Different responses other than the formation of DNA-adducts between the livers of carcinogen-resistant rats (DRH) and carcinogen-sensitive rats (Donryu) to 3'-methyl-4-dimethylaminoazobenzene administration.
Yan Y; Higashi K; Yamamura K; Fukamachi Y; Abe T; Gotoh S; Sugiura T; Hirano T; Higashi T; Ichiba M
Jpn J Cancer Res; 1998 Aug; 89(8):806-13. PubMed ID: 9765615
[TBL] [Abstract][Full Text] [Related]
3. Remarkable difference in the incidence of liver tumors by N-nitrosodimethylamine in carcinogen-resistant DRH rat and its parental strain Donryu rat.
Yan Y; Higashi K; Tanimoto A; Fukamachi Y; Itoh H; Abe T; Higashi T
J UOEH; 1998 Dec; 20(4):307-14. PubMed ID: 9883481
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo. Association with aberrant localization of connexin proteins.
Krutovskikh VA; Mesnil M; Mazzoleni G; Yamasaki H
Lab Invest; 1995 May; 72(5):571-7. PubMed ID: 7745951
[TBL] [Abstract][Full Text] [Related]
5. Changes in cellular distribution of connexins 32 and 26 during formation of gap junctions in primary cultures of rat hepatocytes.
Kojima T; Yamamoto M; Tobioka H; Mizuguchi T; Mitaka T; Mochizuki Y
Exp Cell Res; 1996 Mar; 223(2):314-26. PubMed ID: 8601409
[TBL] [Abstract][Full Text] [Related]
6. Low p38 MAPK and JNK activation in cultured hepatocytes of DRH rats; a strain highly resistant to hepatocarcinogenesis.
Honmo S; Ozaki A; Yamamoto M; Hashimoto N; Miyakoshi M; Tanaka H; Yoshie M; Tamakawa S; Tokusashi Y; Yaginuma Y; Kasai S; Ogawa K
Mol Carcinog; 2007 Sep; 46(9):758-65. PubMed ID: 17546627
[TBL] [Abstract][Full Text] [Related]
7. Nafenopin causes protein kinase C-mediated serine phosphorylation and loss of function of connexin 32 protein in rat hepatocytes without aberrant expression or localization.
Elcock FJ; Deag E; Roberts RA; Chipman JK
Toxicol Sci; 2000 Jul; 56(1):86-94. PubMed ID: 10869456
[TBL] [Abstract][Full Text] [Related]
8. Blunt cell growth potential in carcinogen resistant inbred DRH rats.
Yamashiro K; Yan Y; Fukamachi Y; Gotoh S; Higashi K; Ohtsuki M; Hamada Y; Higashi T
Exp Anim; 2000 Jan; 49(1):47-50. PubMed ID: 10803362
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MAP kinase activity moderates changes in expression and function of Cx32 but not claudin-1 during DNA synthesis in primary cultures of rat hepatocytes.
Kojima T; Yamamoto T; Lan M; Murata M; Takano K; Go M; Ichimiya S; Chiba H; Sawada N
Med Electron Microsc; 2004 Jun; 37(2):101-13. PubMed ID: 15221652
[TBL] [Abstract][Full Text] [Related]
10. Different mechanisms of modulation of gap junction communication by non-genotoxic carcinogens in rat liver in vivo.
Cowles C; Mally A; Chipman JK
Toxicology; 2007 Aug; 238(1):49-59. PubMed ID: 17624652
[TBL] [Abstract][Full Text] [Related]
11. Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters.
Neveu MJ; Babcock KL; Hertzberg EL; Paul DL; Nicholson BJ; Pitot HC
Cancer Res; 1994 Jun; 54(12):3145-52. PubMed ID: 8205533
[TBL] [Abstract][Full Text] [Related]
12. Genetic resistance to chemical carcinogen-induced preneoplastic hepatic lesions in DRH strain rats.
Zeng ZZ; Higashi S; Kitayama W; Denda A; Yan Y; Matsuo K; Konishi Y; Hiai H; Higashi K
Cancer Res; 2000 Jun; 60(11):2876-81. PubMed ID: 10850431
[TBL] [Abstract][Full Text] [Related]
13. Reduced T cell response in carcinogen-sensitive Donryu rats compared with carcinogen-resistant DRH rats.
Mise-Omata S; Sugiura T; Higashi K; Yamashita U
Jpn J Cancer Res; 1999 Dec; 90(12):1277-84. PubMed ID: 10665643
[TBL] [Abstract][Full Text] [Related]
14. Induction of tight junctions in human connexin 32 (hCx32)-transfected mouse hepatocytes: connexin 32 interacts with occludin.
Kojima T; Sawada N; Chiba H; Kokai Y; Yamamoto M; Urban M; Lee GH; Hertzberg EL; Mochizuki Y; Spray DC
Biochem Biophys Res Commun; 1999 Dec; 266(1):222-9. PubMed ID: 10581193
[TBL] [Abstract][Full Text] [Related]
15. Investigation of possible involvement of several genes related to development of hepatocarcinogenesis in rats.
Todaka N; Higashi K; Yan Y; Abe T; Yamashiro K; Hiai H
J UOEH; 2000 Jun; 22(2):119-32. PubMed ID: 10862407
[TBL] [Abstract][Full Text] [Related]
16. Non-genotoxic carcinogens: early effects on gap junctions, cell proliferation and apoptosis in the rat.
Mally A; Chipman JK
Toxicology; 2002 Dec; 180(3):233-48. PubMed ID: 12393293
[TBL] [Abstract][Full Text] [Related]
17. Low selection of preneoplastic hepatocytes after treatment with the 2-acetylaminofluorene diet-partial hepatectomy regimen in the liver of hepatocarcinogenesis-resistant DRH strain rats.
Imai K; Yamamoto M; Tanaka H; Hashimoto N; Miyakoshi M; Honmou S; Yoshie M; Tamakawa S; Yaginuma Y; Kasai S; Ogawa K
Oncol Rep; 2007 Jan; 17(1):55-60. PubMed ID: 17143478
[TBL] [Abstract][Full Text] [Related]
18. Identification of connexin36 in gap junctions between neurons in rodent locus coeruleus.
Rash JE; Olson CO; Davidson KG; Yasumura T; Kamasawa N; Nagy JI
Neuroscience; 2007 Jul; 147(4):938-56. PubMed ID: 17601673
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects of 3'-methyl-4-dimethylaminoazobenzene, 2-methyl-4-dimethylaminoazobenzene, and 2-acetylaminofluorene on rat liver DNA stability and new synthesis.
Yager JD; Potter VR
Cancer Res; 1975 May; 35(5):1225-34. PubMed ID: 804349
[TBL] [Abstract][Full Text] [Related]
20. The topological structure of connexin 26 and its distribution compared to connexin 32 in hepatic gap junctions.
Zhang JT; Nicholson BJ
J Membr Biol; 1994 Apr; 139(1):15-29. PubMed ID: 8071984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]